NanJing Public Utilities Development frequently takes action to transform, will the battery-swapping Technology company Yugu reach the public market through a curve? | Quick reading of the announcement.

① NanJing Public Utilities Development plans to acquire YuGu Technology, whose main Business provides battery swapping services for delivery riders, having halted its IPO process six months ago; ② In recent years, while YuGu Technology's revenue has grown, its gross margin has continued to decline, and NanJing Public Utilities Development has fallen into a loss trap; ③ NanJing Public Utilities Development is frequently acquiring external Assets to accelerate its transformation towards New energy Fund, and recently acquired NanJing Energy Network.

cls.cnJan 10 10:44 ET

December 24 review: With sufficient reserve momentum this week, next week saw a substantial increase in trading volume as block orders targeted 5 stocks.

On December 24th, the three major indices opened higher and then fell back, with the Shanghai Composite Index maintaining a low consolidation, while the ChiNext Price Index led the decline in the two cities. In terms of sectors, the medical sector collectively surged, with traditional Chinese medicine stocks leading the gains, while food processing, retail, and other consumer stocks were active against the trend; new energy sectors such as lithium batteries, photovoltaics, and energy storage all fell across the board, with the heavyweight Contemporary Amperex Technology dropping over 9% intraday. The indices continued to weaken in the afternoon, with the ChiNext Price Index's decline expanding to 2.7% at one point. Stocks related to nurturing diamonds and the non-fungible token (NFT) concept surged, while sectors like autos, rare earths, fluorine chemicals, and digital currency remained sluggish. Overall, market sentiment is cooling, and individual stocks are showing a general downward trend in the two cities

新浪財經綜合Dec 24, 2021 02:46 ET

On September 10, 11 companies, including Tiantan Biology and China Satcom, announced positive results.

1. Tiantan Biology: Chengdu Rongsheng related production site has passed the drug GMP compliance test Tiantan Biological announcement, Chengdu Rongsheng developed "Human Coagulation Factor Ⅷ" meets the relevant requirements of drug registration. At the same time, Chengdu Rongsheng related production sites have passed the drug GMP compliance inspection, and obtained the "Drug GMP on-the-spot Inspection result notice" issued by the Sichuan Provincial Drug Administration. two。 China Satcom: China Star 9B satellite will be delivered to the company after passing the in-orbit test. China Satcom announced that the China Star 9B satellite launched on September 9 will be delivered to the company's operation management after passing the in-orbit test.

證券之星Sep 10, 2021 05:58 ET

Analysis of the daily limit of the Great Oriental on September 8: car sales, trust, community group buying concept hot stocks

Securities Star data Center News, the Great East closed by the daily limit, with a closing price of 6.39 yuan. The stock rose by the daily limit at 11:22, but did not open the limit. The closing capital was 37.0422 million yuan, accounting for 0.66% of its current market value. In terms of capital flow data, the net inflow of main funds on the same day was 55.846 million yuan, the net inflow of hot capital was 33.5676 million yuan, and the net outflow of retail funds was 34.9224 million yuan. The flow of funds in the past five days is shown in the following table: the stock is a hot stock of car sales, trust and community group buying concepts. On the same day, the concept of car sales rose 2.02%, the concept of trust rose 1.68%, and the community.

證券之星Sep 8, 2021 03:11 ET

A picture to understand the Great Oriental 2021 China News

According to the Securities Star data Center, the Great Oriental 2021 report shows that the company's main income is 4.249 billion yuan, up 27.83% from the same period last year; net profit from home is 152 million yuan, up 27.56% from the same period last year; deducting 119 million yuan from non-net profit, up 29.72% from the same period last year; debt ratio 56.02%, investment income 13.9295 million yuan, financial expenses 15.4421 million yuan, gross profit 14.64%. There are three new shareholders in this period. Shanghai Xitai Investment Management Co., Ltd.-Xitai Dongsheng No. 1 private equity fund holds 5.7722 million shares, accounting for 0. 5% of the outstanding shares.

證券之星Aug 26, 2021 21:50 ET

On July 26, four companies announced negative results: shareholders of Bank of China Securities intend to reduce their holdings of no more than 2.5% of the company's shares.

Zhongke Haixun shareholder Pingdingshan Acoustics plans to reduce its shares by no more than 6%. The shareholder Pingdingshan Haixun Acoustics Technology Investment Partnership (Limited Partnership), which holds 24281250 shares (accounting for 20.57% of the total share capital of the company), plans to reduce its holdings in total no more than 7083000 shares in the form of centralized bidding or bulk transactions within 6 months, accounting for 6.00% of the total share capital of the company. Shen Hongshan, a shareholder of Haowu shares, intends to reduce its shareholding by no more than 3%. Shen Wanhong property, a shareholder who holds 59447738 shares of the company (8.94% of the company's total share capital).

證券之星Jul 25, 2021 21:07 ET